Michael is an experienced C-suite executive with deep expertise in corporate development, mergers & acquisitions (M&A), strategy, equity & debt capital markets, equity investing/venture capital, market development, partnerships.
He previously worked at the General Electric Company (“GE”) for over 21 years, having joined the company in 1998. From 1998 through 2010, he was the Executive Vice President, Corporate Development/M&A, for GE Healthcare (“GEHC”) based in London, United Kingdom, and Milwaukee, Wisconsin. In that role, he was a member of the senior leadership team at GEHC and was responsible for developing the overall strategy for the business and leading its corporate development, M&A, equity investing and partnership activities. During his time at GEHC, the business grew from approximately $2 billion to $18 billion in annual revenues and completed over 100 transactions worldwide valued in excess of $20 billion. He was also responsible for launching GE’s healthcare venture fund in 2010, which made growth capital and venture investments in numerous med-tech companies.
From 2014 until his retirement from GE he served as its Executive Vice President, Corporate Development/M&A, responsible for leading GE’s corporate development and M&A across all of its industrial businesses. Over the 2014-2019 time period, GE completed over $50 billion in mergers and acquisitions and $30 billion in divestitures.
Prior to joining GE, Michael spent over a decade working as an investment banker in New York and San Francisco, primarily as an M&A advisor for technology companies. He graduated from Princeton University with an A.B. in Economics, with honors, in 1987. Michael resides in Greenwich CT with his wife Kelly and their three children.